Skip to main content
Calliditas Therapeutics AB (publ) (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price on Sep 20, 2024

CALT Revenue

Calliditas Therapeutics AB had revenue of 559.78M SEK in the quarter ending June 30, 2024, with 107.80% growth. This brings the company's revenue in the last twelve months to 1.60B, up 39.27% year-over-year. In the year 2023, Calliditas Therapeutics AB had annual revenue of 1.21B with 50.32% growth.

Revenue (ttm)
1.60B SEK
Revenue Growth
+39.27%
P/S Ratio
n/a
Revenue / Employee
7,379,788 SEK
Employees
217
Market Cap
1.10B USD

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.21B404.01M50.32%
Dec 31, 2022802.88M573.53M250.07%
Dec 31, 2021229.35M228.47M26,141.08%
Dec 31, 2020874.00K-183.96M-99.53%
Dec 31, 2019184.83M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CALT News

More News